US Congress House Bill 2921 (Prior Session Legislation)

---

Sponsorship: Slight Partisan Bill (Republican 3-1)
Status: Introduced on June 25 2015 - 25% progression, died in committee
Action: 2015-06-26 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Patients First Act of 2015 This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that the techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act. HHS must issue guidelines to ensure that any research (including any clinical trial) supported under this Act: (1) is clearly consistent with the standards established in this Act, if conducted using human cells; and (2) is prioritized in terms of potential for near-term clinical benefit in human patients. HHS must report on peer reviewed stem cell research proposals that were not funded.

Patients First Act of 2015

Rep. Randy Forbes [R-VA]

Rep. Daniel Lipinski [D-IL]

Rep. Jeff Miller [R-FL]

Rep. Jeb Hensarling [R-TX]

Date	Chamber	Action
2015-06-26	House	Referred to the Subcommittee on Health.
2015-06-25	House	Referred to the House Committee on Energy and Commerce.
2015-06-25	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/house-bill/2921/all-info
Text	https://www.congress.gov/114/bills/hr2921/BILLS-114hr2921ih.pdf